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Abstract:  We  report  application  of  two-photon  excitation  of  europium 
chelates  to  immunolabeling  of  epidermal  growth  factor  receptor  (EGFR) 
cell  surface  proteins  on  A431  cancer  cells.  The  europium  chelates  are 
excited with two photons of infrared light and emit in the visible. Europium 
chelates are conjugated to antibodies for EGFR. A431 (human epidermoid 
carcinoma)  cells  are  labeled  with  this  conjugate  and  imaged  using  a 
multiphoton microscope. To minimize signal loss due to the relatively long-
lived Eu
3+ emission, the multiphoton microscope is used with scanning laser 
two-photon excitation and non-scanning detection with a CCD. The chelate 
labels  show  very  little  photobleaching  (less  than  1%  during  continuous 
illumination  in  the  microscope  for  20  minutes)  and  low  levels  of 
autofluorescence  (less  than  1%  of  the  signal  from  labeled  cells).  The 
detection limit of the europium label in the cell assay is better than 100 
zeptomoles. 
© 2011 Optical Society of America 
OCIS  codes:  (180.4315)  Nonlinear  microscopy;  (170.1530)  Cell  analysis;  (170.2520) 
Fluorescence microscopy; (170.5810) Scanning microscopy; (190.7220) Upconversion 
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1. Introduction 
Lanthanide ions complexed with multidentate ligands (lanthanide chelates) offer interesting 
properties  for  cellular  imaging  and  other  biological  and  medical  applications.  When 
complexed with a bifunctional ligand, they may be readily conjugated to biomolecular probes. 
Lanthanide chelate reporters have been applied to immunoassays for many years [1,2]. The 
long  excited  state  lifetimes  of  certain  lanthanides  allow  for  temporal  autofluorescence 
rejection by using time resolved measurements and the large Stokes shifts help discriminate 
against background light. The narrow emission bands of lanthanide ions present opportunities 
for  multiplexing.  Lanthanide  chelates  do  not  self-quench,  allowing  for  many  labels  to  be 
conjugated to a molecular probe. Recent work has examined methods to achieve upconverted 
emission from lanthanide chelates (near infrared excitation and visible emission) [3] either 
through direct excitation of lanthanide ions such as trivalent erbium or thulium [4] or by two-
photon  excitation  of  a  sensitizing  molecule  followed  by  efficient  energy  transfer  to  a 
lanthanide ion such as europium [5–12]. Like organic dyes, the lanthanide chelates are small 
in size yet the lanthanide ions are immune to photobleaching like the much larger quantum 
dots [13,14] and upconverting phosphors [15,16]. Photobleaching of a sensitizing antenna is 
an issue discussed in section 3.4. Upconverted emission from lanthanide chelates tends to 
exhibit minimal autofluorescent background from the biological matrix. Photobleaching and 
autofluorescence are significant limitations for fluorescent reporters today. Other advantages 
that stem from near infrared excitation include deeper penetration of thick biological samples 
and potentially lower phototoxicity. 
Here we report the practical application of a two-photon-excited europium chelate reporter 
to a cell-based assay using a microscope combining scanned excitation and CCD detection. 
Photobleaching, autofluorescence, and detection limits are quantified. The assay targets EGFR 
on  A431  (human  epidermoid  carcinoma)  cells.  Elevated  expression  of  EGFR  is  a  tumor 
marker for squamous carcinomas. 
2. Experiment 
2.1. Excitation method 
The excitation pathway for the two-photon-excited emission from our Eu chelate is shown in 
Fig.  1.  Europium  emission  is  produced  through  two-photon  excitation  of 
naphthoyltrifluoroacetonate (NTA, the sensitizer) followed by energy transfer to the Eu
3+. A 
high peak power pulsed laser (a femtosecond laser) is required in order to obtain a reasonable 
two-photon excitation due to the lack of an intermediate state for NTA. Energy transfer from 
the excited NTA ligand to Eu
3+ has a high probability owing to the proximity of the energy 
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use the strong emission on the hypersensitive 
5D0  
7F2 transition at ~615 nm for microscopic 
imaging. 
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Fig. 1. Schematic of energy transfer from sensitizer to Eu
3+. 
Our sensitized Eu chelate is formed in situ by simply adding a solution of NTA to cells, 
which  have  a  EuDOTA  streptavidin  conjugate  on  their  surface.  Because  the  DOTA  is 
conjugated through one of its carboxylates, the DOTA chelate covers only 7 coordination sites 
on the Eu
3+ ion. This leaves 2 coordination sites open to be filled by solvent or in this case 
NTA. 
Figure  2  shows  spectra  of  the  EuDOTA  chelate  before  and  after  conjugation  to 
streptavidin  (SA)  and  with  NTA  added.  These  spectra  were  taken  with  a  conventional 
fluorimeter (single photon excitation with Perkin Elmer 650-10S). The EuDOTA spectrum 
does not change qualitatively when it is conjugated to SA. The EuDOTA emission is excited 
at 395 nm, which corresponds to an f–f transition of Eu
3+. Consequently, the spectrum, which 
features  a  dominant  peak  at  590  nm,  is  relatively  weak.  When  NTA  is  added  and  the 
excitation wavelength is changed to 370 nm, the emission becomes approximately 100 times 
stronger and the dominant peak shifts to 615 nm. Although the direct f-f excitation of the 
EuDOTA is somewhat weak, it is quite sufficient for titration of the EuDOTA streptavidin 
conjugate. 
Our strategy of producing a sensitized Eu chelate in situ allows us to use a relatively 
inexpensive, commercially available bifunctional ligand for conjugation to the biomolecular 
probe  and  obviates  any  possible  complications  involving  the  sensitizing  moiety  during 
conjugation. 
2.2. Multiphoton microscope 
Figure 3 shows the experimental apparatus for multiphoton microscopy. The most significant 
aspect of this microscope is the use of scanned excitation and non-scanned detection using a 
CCD. Multiphoton and other nonlinear microscopies use a scanned laser beam for excitation 
since  the  optical  response  is  nonlinear  with  the  laser  power  density.  Thus,  much  higher 
detection efficiency is possible by scanning a focused spot of high intensity rather than using 
illumination with a larger spot and lower intensity. In most cases, imaging is achieved using 
the same scanning mechanism and detection a photomultiplier, as is performed with confocal 
microscopy.  When  using  fluorescent  dyes  for  multiphoton  microscopy,  for  example,  the 
lifetime of the dye is quite short (in the nanosecond range). When using lanthanide emitters 
however, the lifetimes are typically in the range of hundreds of microseconds, which is long 
compared to a typical single pixel dwell time for a laser-scanning microscope. In principle, 
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laser intensity on one pixel for longer periods of time can lead to thermal damage of the 
sample. Furthermore, the image acquisition time in this case is limited by the emission rate of 
the lanthanide as opposed to adjusting the image acquisition time to achieve a desired signal-
to-noise ratio. Our microscope uses scanned laser excitation and non-scanned detection with a 
CCD [19], a configuration usually used with multifocal multiphoton microscopy [20] to speed 
image acquisition. Here we use this configuration to avoid loss of light due to the limited 
dwell  time  on  a  given  pixel  in  a  confocal  arrangement.  Since  each  pixel  of  the  CCD  is 
continuously illuminated by the imaged lanthanides such loss of light is avoided. 
 
Fig. 2. Spectra of Eu DOTA-NHS before conjugation (a) and after conjugation to streptavidin 
with and without NTA added (b). These spectra were taken in a conventional fluorimeter. 
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Fig. 3. Schematic of multiphoton microscope. 
The  light  source  for  the  microscope  was  a  Spectra  Physics  Tsunami  Ti:sapphire  laser 
tuned  to  740  nm.  The  beam  was  passed  through  a  telescope  (not  shown)  to  provide  an 
appropriate beam size and convergence. A pair of mirrors controlled by galvonometers was 
used to provide the scanning. Two lenses in a 4-f configuration are used to image the plane of 
the galvanometer mirror pair onto the back aperture of the microscope objective. A dichroic 
mirror was used to reflect the infrared beam into the microscope while transmitting the visible 
light onto the CCD (Q Imaging Retiga EXi). The emission was filtered using a combination of 
a 600 nm long pass filter and a 620 nm short pass filter. An additional 640 nm short pass filter 
completely  blocks  the  740  nm  laser  radiation.  The  615  nm  Eu
3+  emission  is  selectively 
captured in the 600-620 nm window created by the filter set. 
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As a chelating ligand for the work, we use 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic 
acid (DOTA). Conjugates of EuDOTA to streptavidin (SA) were prepared by two different 
methods. Both protocols involved a bifunctional DOTA-NHS (N-hydroxysuccinamide) ligand 
obtained from Macrocyclics. The two protocols differed in whether the Eu
3+ was inserted in 
the DOTA macrocycle before or after conjugation to the streptavidin. 
In the first method, the Eu
3+ was inserted into the bifunctional DOTA before conjugation 
to SA. We dissolved 22 mg of DOTA-NHS, provided as the PF6
- salt, in 1 mL water and the 
pH adjusted to between 5 and 6 with NaOH. A molar equivalent of EuCl3 was added and 
allowed to react for 30 minutes. A 50-uL aliquot of the reaction mixture was then added to 
200 µL of streptavidin (5 mg/mL) in carbonate coupling buffer (pH 9). The coupling reaction 
between the NHS and lysine residues on streptavidin was allowed to proceed for 2 hours. The 
unreacted  EuDOTA-NHS  was  separated  from  the  SA  conjugate  by  size  exclusion 
chromatography  on  a  Sephadex  column  using  a  PBS  (phosphate  buffered  saline)  elution 
buffer (pH 7.2). Comparison of the EuDOTA SA conjugate emission spectrum with that of 
the  initial  EuDOTA-NHS  solution  (with  known  DOTA  concentration)  indicated  that  the 
conjugate  contained  4  EuDOTA  chelates  per  SA  on  average.  The  SA  concentration  was 
determined spectrophotometrically. We assume that the insertion of Eu
3+ into the DOTA was 
90% complete to obtain the number four chelates per SA. A potential problem with the first 
method is that the NHS may hydrolyze during insertion of Eu
3+ prior to the coupling reaction. 
The half-life of NHS in water is 4 to 5 hours and hydrolysis occurs even faster in basic pH. 
Therefore the time for the Eu
3+ insertion into DOTA must be strictly limited. Consequently, 
the insertion at pH 5-6 may have been incomplete in 30 minutes. 
We have used a second method that avoids hydrolysis of the NHS during insertion of Eu
3+ 
by inserting the Eu
3+ after conjugation to SA. 20 mg of DOTA-NHS was dissolved in 0.5 mL 
of water and the solution pH adjusted to 5 with NaOH. A 100-µL aliquot of this solution was 
added to 200 µL of streptavidin (5mg/mL) in coupling buffer and allowed to react for 2 hours. 
The unreacted DOTA-NHS was separated from the SA conjugate by size exclusion as before 
except that the elution was performed with TRIS buffer. Use of TRIS buffer rather than PBS 
was  very  important  to  the  post-conjugation  insertion  of  Eu
3+  since  EuPO4  is  insoluble. 
Emission spectra indicated that the Eu
3+ was successfully inserted into the DOTA conjugated 
to  SA  as  evidenced  by  the  EuDOTA  emission  spectrum.  Comparison  of  the  conjugate 
spectrum to that of a known concentration of EuDOTA-NHS showed that we were able to 
achieve  a  higher  level  of  labeling  (6-7  EuDOTA  per  SA)  using  the  second  conjugation 
method. 
2.4. Cell assay protocol 
A schematic diagram of the  overall assay is shown in  Fig. 4. The A431 cells fixed with 
methanol  were  incubated  with  a  monoclonal  anti-EGFR  primary  antibody  obtained  from 
Neomarkers. The cells were subsequently incubated with a biotinylated secondary antibody  
 
 
Fig. 4. Schematic representation of cell-based assay using europium chelates 
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recommended  in  the  protocols  provided  by  the  antibody  vendors.  The  final  step  was 
incubation with the EuDOTA streptavidin conjugates described above. Prior to microscopic 
imaging, the cells were rinsed with TRIS buffer and deionized water. The cells were then 
blanketed with a layer of NTA by evaporation of a 5 µL drop of 0.1 mM NTA ethanol on top 
of the cells. This produces a layer of sensitizing molecules that absorb two 740 nm photons 
and transfer energy to Eu
3+, which then emits radiation at 615 nm. We also performed the 
assay  with  a  FITC-SA  conjugate  using  a  conventional  fluorescence  microscope  for 
comparison with the Eu
3+ labels. 
After taking the initial images, we optionally covered the cells with a drop of 0.1 M KHP 
(potassium hydrogen phthalate) solution. Only a small portion of the entire cell sample is 
subjected to KHP treatment. This allows for examination of other cells in the sample at a 
future time. We hypothesize that the low pH of the KHP solution releases Eu
3+ from the 
DOTA  macrocycle  by  protonating  its  acetates  and  nitrogens,  similar  to  the  strategy  of 
Hemmila et al. [1] except without the surfactant. The presence of excess NTA may assist in 
removal of the Eu
3+ from the DOTA. The Eu
3+ might then be directly complexed by NTA 
resulting  in  significantly  better  sensitization.  Immediately  upon  addition  of  the  KHP,  the 
image becomes significantly brighter for a short time, but then the image intensity decreases. 
We ascribe the drop in intensity to release of the europium label from the cell surface as 
evidenced  by  the  blurring  of  the  contrast  and  a  gradual  drop  in  the  signal  level.  The 
persistence of a lower signal level in a stable image after a few minutes may be due to a 
portion of the europium complex that remains adsorbed on the cell surface. The net result of 
the KHP treatment is not necessarily a brighter image but a more stable image as dry samples 
were not stable over long periods in the laser due to thermal effects. This optional step in the 
protocol  provides  evidence  that  the  signal  was  indeed  derived  from  the  europium  label 
without taking spectra and also allowed us to perform photostability measurements without 
complications due to thermal effects. Although we don’t have independent confirmation of the 
lanthanide species under each condition it is quite reasonable to expect that the lanthanide 
remains  in  the  DOTA  macrocycle  when  only  NTA  is  applied  since  the  Eu
3+  contrast  is 
strongly localized, as is typical for antibody-based surface labeling. When KHP is added, the 
contrast becomes quite diffuse, indicating that the lanthanide is no longer localized by the 
antibody complex. 
3. Results 
Figure 5 shows images of A431 cells as (a) a bright field image, (b) a two-photon-excited 
luminescent image after application of the NTA layer, (c) an overlay of brightfield and two-
photon-excited images, and (d) and an image after KHP addition. 
Figure 6 shows images of cells that were subjected to the same protocols as the cells in 
Fig. 4 except that the primary antibody was omitted. The image illustrates the specificity of 
the assay as well as the lack of autofluorescence. Figure 7 features bare cells examined in the 
multiphoton microscope that have been blanketed with NTA. This image further underscores 
the lack of autofluorescence for the two-photon-excited lanthanide assay. 
3.1. Determination of detection limit 
We have determined the detection limit for the europium label through signal-to-noise ratio 
measurements  on  a  known  quantity  of  the  EuDOTA  label  with  NTA.  A  solution  of  the 
europium label was prepared at 0.01 molar concentration. Serial dilution was used to prepare 
solutions at concentrations of 1 × 10
4 and 1 × 10
5 molar concentrations. Aliquots of these 
solutions (5 microliters) were applied to a microscope slide using a micropipette to cover an 
area of 1 cm
2. The diluted label concentrations and area information are used to derive a label 
concentration (5 × 10
5 femtomoles/cm
2 for 100-fold dilution; this dilution is the basis for the 
remaining calculations). The width of an area viewed by a single pixel on the camera was 
determined through calibration using a resolution test target and found to be 0.118 microns, or  
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Fig. 5. Images of A431 cells labeled with EuDOTA (a) brightfield image; (b) two-photon-
excited  image;  (c)  two-photon-excited  image  (red)  overlaid  on  brightfield  image;  (d)  two-
photon-excited image after addition of KHP. 
   
 
(a)  (b) 
 
Fig.  6.  Bright  field  (a)  and  two-photon-excited  luminescence  (b)  images  of  A431  cells 
following protocol of Fig. 4 except without primary antibody. 
an area of 1.4 × 10
10 cm
2. Thus there were 70 zeptomoles in the area viewed by a single CCD 
pixel. The fact that this size is below the diffraction limit is not important because we are 
determining signal levels per area and blurring does not change this number. CCD signals in 
counts per second were measured while the laser power was maintained at a constant level. 
This measurement yields a signal size of ~75 counts for the solution containing 70 zeptomoles 
in the area viewed by a single CCD pixel. Since a signal level of 75 counts is well above the 
read  noise  and  dark  current  of  the  camera,  we  can  detect  below  100  zeptomoles  of  the 
europium chelate label. 
#146881 - $15.00 USD Received 2 May 2011; revised 13 Jun 2011; accepted 11 Jul 2011; published 13 Jul 2011
(C) 2011 OSA 1 August 2011 / Vol. 2,  No. 8 / BIOMEDICAL OPTICS EXPRESS  2261   
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Fig. 7. Bright field (a) and two-photon-excited luminescence (b) images of bare A431 cells. 
It is not too surprising that detection is possible at the 100 zeptomole level. Because the 
experimental  method  does  not  descan  the  emitted  Eu
3+  luminescence,  there  is  no  loss  of 
efficiency in light collection due to a pixel dwell time that is less than the luminescence 
lifetime. In addition, the lanthanide complex has two qualities that allow for a low detection 
limit. First, the absorption cross section is greatly enhanced by energy transfer from the NTA. 
Second, the quantum efficiency of Eu
3+ can be relatively high when protected by ligands such 
as DOTA and NTA. Images acquired with and without the addition of KHP have similar 
brightness  indicating  that  the  exact  ligand  surrounding  the  Eu
3+  is  not  critical.  Although 
multiphoton  excitation  is  less  efficient  than  single  photon  excitation,  single  dye  molecule 
detection has been demonstrated using two-photon excitation [21],  which is roughly 5 orders 
of magnitude better than our detection limit. On comparing two-photon excitation of a dye 
molecule with the lanthanide chelate, the dye has a much shorter lifetime, and hence more 
detected  photons  per  second,  while  the  lanthanide  chelate  is  quite  insensitive  to 
photobleaching  and  autofluorescence.  The  difference  in  lifetime  and  the  energy  transfer 
efficiency may be the dominant factors in the worse detection limit for the lanthanide chelate. 
It is also of interest to know the quantity of label on the cells. Using the above calibration 
of counts per femtomole and cell areas known from the calibration for the imaged area per 
pixel, we find signal levels of 0.69 ± 0.36 femtomoles label per cell. There are roughly 6 to 7 
chelate molecules per probe molecule. Thus the calibrated system method yields 0.11 ± 0.05 
femtomoles of probe per cell. 
For  comparison,  we  can  consider  the  total  quantity  of  probe  applied  to  the  cells  for 
imaging. The purified stock probe EuDOTA SA conjugate solution had a concentration of 0.5 
mg/mL. This number was verified two ways: (1) through spectrophotometric measurement of 
the protein concentration at 280 nm, and (2) through comparison of the different fractions of 
the 1 mg/mL streptavidin sample after label conjugation and purification. This solution was 
diluted by a factor of 20 and a 0.3 mL aliquot was applied to the slide well of prepared cells. 
The  number  of  cells  per  slide  well  was  determined  to  be  5  ×  10
4  cells  per  well  using  a 
hemocytometer.  Microscopic  examination  of  the  cell  density  supports  this  number.  The 
molecular weight of the streptavidin is 53,000 (provided by the vendor). If all of the labeled 
probe bound to the cells, the maximum labeled probe on a cell was 2.8 femtomoles. This 
value  is  2.7  femtomoles  larger  than  the  number  determined  from  the  system  calibration 
method in the previous paragraph. This is not surprising because most of the conjugated probe 
typically washes off the cells after incubation. 
Finally, we can compare the measured signal levels with the number of probe molecules 
per cell. The number of EGF receptors (EGFR) on A431 cells is about 2 × 10
6 [22]. It is 
possible for  more than one  probe to bind to each receptor site. This amplification is due 
primarily to the multiple biotin molecules on the secondary antibody, which provide multiple 
binding sites for the streptavidin-label conjugates. In addition, some primary antibodies may 
have more than one secondary antibody bound to them. The extent of multiple binding of the 
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the label. The chelating molecule for our label is quite small, with a molecular weight of 404 
Daltons. The vendor for the secondary antibody (biotinylated donkey anti-mouse IgG from 
Jackson ImmunoResearch Laboratories, Inc.) has found that up to 10 conjugate molecules can 
bind to a single primary antibody receptor site for small conjugates, which is the case for us. 
Thus an upper bound for the number of probe molecules is 2 × 10
7, or 0.03 femtomoles/cell. 
This approximate calculation is 0.08 femtomoles smaller than 0.11 femtomoles/cell calculated 
from the calibrated system method. 
3.2. Comparison with FITC labeling 
We have compared our results with those obtained using fluorescein isothiocyanate (FITC), a 
widely used fluorescent reporter. The cell assays for FITC and the europium chelates were 
performed using the same concentrations and conditions for the application of the primary 
antibody,  secondary  antibody,  and  the  streptavidin-label  conjugate  that  we  used  for  the 
europium chelate label. Images of the positive and negative controls for the FITC assay are 
shown in Fig. 8. The images for the FITC-labeled cells are quite similar to those obtained 
using the europium chelate label in  Fig. 5, except that the europium chelate label has no 
discernable background in the negative control assay in  Fig. 6. Fluorescein is one of the 
brightest optical labels known, and is often used for single molecule detection experiments 
(one molecule is 1.7 × 10
3 zeptomoles). Because of photobleaching however, the imaging 
time for single molecules is limited. 
3.3. Determination of autofluorescence 
Figures  4  and  5  illustrate  that  autofluorescence  is  extremely  low.  We  quantified  the 
autofluorescence by taking an image of cells without the Eu
3+ chelate reporter using a very 
long exposure time (1.2 minutes). Taking a ratio of the signal from labeled cells to the signal 
in the absence of reporter, we obtain a ratio of 7 × 10
3, which is less than 1% of the signal 
from labeled cells. 
3.4. Determination of photobleaching 
Figure 9 demonstrates the photostability of the cell images. The average pixel intensity for a 
two-photon-excited luminescence image of cells treated with KHP is plotted as a function of 
time. The intensity remains stable over a twenty minute period with a standard deviation of 
1%. While the europium cannot photobleach, the organic sensitizer should be susceptible to 
photobleaching. One possible rationale for the reduced photobleaching observed in Fig. 9 is 
related  to  the  long-lived  triplet  state,  which  is  generally  believed  to  be  the  source  of 
photobleaching. As shown in Fig. 1, energy transfer can occur rapidly between the triplet state 
and the nearby lanthanide ion that it sensitizes. Thus the coupling of the triplet state to the 
lanthanide ion can shorten the triplet state lifetime and reduce the amount of photobleaching. 
Another factor for these studies is that the excess NTA could compensate for photobleaching. 
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Fig. 8. Positive (a) and negative (b) control images of A431 cells labeled with FITC. 
 
Fig. 9. Variation in two-photon-excited europium signal from labeled A431 cells as a function 
of time. 
4. Conclusions 
We  have  demonstrated  imaging  of  EGFR  receptors  on  A431  cells  using  an  multiphoton 
microscope specially adapted to use of lanthanide chelates in which excitation is performed 
with a scanning laser beam and non-scanning detection is performed with a CCD camera. The 
assay  provides  a  detection  limit  of  approximately  100  zeptomoles  of  lanthanide  chelate, 
photobleaching of ~1% over twenty minutes of illumination, and autofluorescent background 
of less than 1%. 
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